# GPT-5.6 Terra / inf-k01

Original final answer, shared by both scoring rounds.

## Bottom-line conclusion

From the supplied locus, the only supported conclusion is:

> A noncoding GWAS signal lies in a region near **G** that contains multiple linked variants spanning **G** and **H**.

This establishes a **statistical association region**, not a causal SNP, a causal regulatory mechanism, or an effector gene. In particular, neither **G** nor **H** can currently be designated the causal/effector gene. Fine mapping, colocalization, and functional perturbation would address progressively more specific questions, but each has distinct assumptions and limits.

---

## Evidence-to-inference-to-conclusion chain

| Step | Evidence required | What can be inferred | What cannot be inferred |
|---|---|---|---|
| 1. GWAS association | A well-controlled GWAS identifies a lead noncoding SNP near G | Genetic variation in the locus is associated with the trait | The lead SNP is causal; G is the effector gene; the mechanism is regulatory |
| 2. Linkage/LD interpretation | Several variants are linked and span G and H | The association may be represented by any of several correlated variants (or an unmeasured variant correlated with them) | Which linked variant causes the association; whether G or H is affected |
| 3. Statistical fine mapping | Association statistics, local LD, variant set and appropriate modelling | A smaller set of variants statistically compatible with causing the signal; possibly posterior probabilities or a credible set | Molecular function, target gene, or proof that the top-ranked variant is causal |
| 4. Colocalization | Trait association plus molecular-QTL association in relevant biological context | Whether the trait and expression/regulatory signal are statistically consistent with sharing a causal variant | That altered expression causes the trait; definitive assignment when LD is complex or signals are unresolved |
| 5. Functional perturbation | Targeted variant and/or gene perturbation in relevant cells or organisms | Whether a candidate variant changes regulatory activity or gene expression; whether perturbing a candidate gene changes a relevant phenotype | Necessarily the in vivo human disease mechanism, unless model/context and causal chain are directly demonstrated |

---

## 1. What the GWAS result establishes

### Supplied evidence
**E1:** “A well-controlled GWAS identifies a lead noncoding SNP near gene G. Several linked variants span G and H. No functional or colocalization data are supplied.”

### Inference
Because the GWAS is described as well controlled, the lead SNP provides evidence that allelic variation at this locus is statistically associated with the studied phenotype. The SNP is noncoding, so the result does not directly identify a protein-altering mechanism.

### Supported conclusion
The locus containing the lead SNP and its linked variants is a **candidate trait-associated region**.

### Unsupported conclusions
The following common inferences are not justified by E1:

- “The lead SNP causes the phenotype.”
- “The lead SNP regulates G.”
- “G is the causal gene because the SNP is near G.”
- “H is irrelevant.”
- “The nearest gene is the effector gene.”
- “There is only one causal variant or one causal gene at the locus.”

Physical proximity is not sufficient for gene assignment. A noncoding variant can affect G, H, another more distant gene, multiple genes, or no gene expression measure available in a particular assay.

---

## 2. Linkage: why the lead SNP is not necessarily causal

### Concept
The GWAS lead SNP is generally the variant with the strongest observed association in the tested data. If several nearby variants are linked—more specifically, in linkage disequilibrium (LD)—their alleles are correlated. Therefore, each linked variant can inherit evidence of association from the same underlying causal signal.

### Application to E1
The supplied linked variants span both **G** and **H**. Thus, the observed lead-SNP association could reflect:

1. the lead SNP itself being causal;
2. another typed linked variant being causal;
3. multiple causal variants in the locus;
4. an untyped or poorly measured causal variant correlated with the reported SNPs;
5. a structural or other variant not represented by the tested SNPs.

### What linkage establishes
Linkage explains why multiple variants across the G–H interval may show association and defines an interval requiring further resolution.

### What linkage does not establish
Linkage does **not** distinguish causal from passenger variants. Nor does it identify the gene through which the association acts. A variant overlapping G and a variant near H can both be associated simply because they are correlated.

**Conclusion at this stage:** the locus, not a specific SNP or gene, is implicated.

---

## 3. Fine mapping: narrowing candidate causal variants

### Purpose
Fine mapping is a statistical attempt to resolve the GWAS signal within its LD block. It typically uses association evidence across variants together with local LD, and may allow one or more independent causal signals.

### Potential inference
A fine-mapping analysis could assign relative support to variants and produce a credible set: a group of variants that collectively contains the causal variant with a stated model-based probability.

For this locus, fine mapping might, for example, reduce the linked variants spanning G and H to a smaller subset. If one candidate received much stronger statistical support than the others, it would become a higher-priority causal-variant hypothesis.

### What fine mapping can establish
- Relative statistical plausibility of variants under the model.
- Whether the data are more consistent with one versus multiple association signals.
- A more focused list for experimental testing.

### What fine mapping cannot establish
Even a highly prioritized variant is not thereby proven causal. Resolution can remain limited because linked variants can have nearly indistinguishable association patterns. Results also depend on:

- accurate local LD representation;
- inclusion and accurate measurement/imputation of candidate variants;
- sample size;
- assumptions about the number of causal variants;
- the statistical model and prior assumptions.

Most importantly, fine mapping alone does not identify whether the causal variant acts through **G**, **H**, another gene, or a non-expression-mediated mechanism.

**Unreported parameter:** E1 supplies no LD values, association statistics for the linked variants, sample size, variant coverage, conditional-analysis results, or fine-mapping results. Therefore, no actual credible set or causal-variant ranking can be inferred here.

---

## 4. Colocalization: connecting a trait signal to a molecular trait

### Purpose
Colocalization compares the GWAS signal with a molecular quantitative-trait locus—for example, a signal affecting expression of G or H—to ask whether both associations are statistically consistent with the **same causal variant**.

For this locus, relevant analyses could compare the trait association with expression or regulatory-QTL signals for **G**, **H**, and other plausible genes in biologically relevant tissues, cell types, developmental stages, and stimulation states.

### Possible outcomes and their interpretation

- **Trait signal colocalizes with a G molecular-QTL signal:**  
  Supports a model in which the same variant may influence both the trait and a molecular measurement involving G.

- **Trait signal colocalizes with an H molecular-QTL signal:**  
  Supports H as an alternative candidate effector gene.

- **Signals colocalize with both G and H:**  
  Could indicate shared regulation, correlated molecular traits, unresolved LD, or more complex regulation; it does not by itself select one gene.

- **No evidence of colocalization:**  
  Could mean distinct causal variants, insufficient power, inadequate molecular-QTL data, an irrelevant tissue/context, or a mechanism not detectable as the measured molecular trait.

### What colocalization can establish
Colocalization can strengthen the hypothesis that a GWAS association and a molecular association share a variant-level genetic basis.

### What it cannot establish
Colocalization does not prove that altered expression of G or H **causes** the phenotype. A shared variant could affect the molecular trait and disease through separate mechanisms, or affect several genes. Apparent colocalization can also be distorted by unresolved multiple signals or high LD.

**Status for E1:** No colocalization data are supplied. Therefore, no molecular link to either G or H is currently supported.

---

## 5. Functional perturbation: testing causal mechanism

### Purpose
Functional studies test the biological predictions generated by fine mapping and colocalization.

### Proposed experiments — not reported evidence

A useful sequence would be:

1. **Variant-focused perturbation**
   - Edit candidate fine-mapped alleles at their endogenous genomic positions.
   - Measure effects on local regulatory activity and on expression of G, H, and other genes in the locus.
   - Use relevant cell types and biological conditions where the locus is plausibly active.

2. **Gene-focused perturbation**
   - Increase, decrease, or otherwise perturb G and H separately.
   - Measure molecular and cellular phenotypes relevant to the GWAS trait.

3. **Mechanistic linkage test**
   - Test whether the variant’s phenotypic effect is reproduced by perturbing the implicated gene and, where feasible, rescued by restoring that gene’s appropriate expression.
   - Determine whether the candidate allele changes the proposed gene in the same direction predicted by the mechanistic model.

### What functional perturbation can establish
A well-designed endogenous allele edit can provide direct evidence that a particular allele changes a molecular phenotype. Gene perturbation can provide evidence that G or H influences a relevant downstream phenotype. Together, these experiments can build a causal chain:

> candidate allele → regulatory/molecular change → effector-gene change → trait-relevant phenotype.

### Limits
Functional results remain context-dependent. Effects may be absent in an inappropriate cell type, developmental stage, stimulation condition, or assay. Artificial perturbations can have dosage or off-target effects, and a cellular phenotype may not capture the human trait. Thus, functional evidence is strongest when allele-specific, endogenous, reproducible, context-appropriate, and connected to a trait-relevant phenotype.

---

## Overall interpretation of the supplied locus

The evidence presently supports only this model:

> One or more variants in an LD region spanning G and H are associated with the trait.

The principal alternatives remain unresolved:

- the causal variant is the lead SNP or another linked variant;
- the effector gene is G, H, another gene, multiple genes, or no gene detectable by standard expression assays;
- the locus contains one or multiple causal signals;
- the mechanism is expression-related, another regulatory mechanism, or another noncoding function.

Accordingly, the correct progression is:

> **GWAS locus identification → LD-aware fine mapping → context-appropriate colocalization → targeted functional perturbation and mechanistic validation.**

At the E1 stage, calling either the lead SNP a causal variant or G an effector gene would exceed the evidence.
